NDA Submission Strategy
A while ago I was engaged in a client project where we developed the launch strategy for a compound targeted for multiple indications....
top of page
Guest Writer: Emma Samuelsson
Jun 24, 20212 min read
Understanding the Difference of Using Static Values vs Uncertainties When Predicting Launch
Prediction has always been a key aspect of the pharmaceutical industry. With huge amount of money being invested in projects or...
Andrew Combs
Jun 24, 20214 min read
Clinical Trial Recruitment Impact on Market Order of Entry & Sales
Clinical development has always been an uncertain endeavor for the pharmaceutical industry. However, with the COVID pandemic, this...
Magnus Ytterstad
Jun 24, 20215 min read
COVID-19 Portfolio Delay Scenarios
The current pandemic is greatly impacting all of us and also the pharmaceutical industry. Difficulties in recruiting and keeping new...
Magnus Ytterstad
Jun 23, 20215 min read
Modeling Fast Track Designation
INTRODUCTION Since 2018, Captario has participated in formulating product strategies for a number of oncology assets. These development...
Magnus Ytterstad
Jun 22, 20215 min read
Evaluating Fast Track Opportunities
Over the past eighteen months I have participated in efforts to develop product strategies for a number of oncology assets. These...
bottom of page